Ligand Pharmaceuticals
LGND
LGND
206 hedge funds and large institutions have $2.28B invested in Ligand Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 73 increasing their positions, 71 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
3% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 71
2% less funds holding
Funds holding: 211 → 206 (-5)
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
Holders
206
Holding in Top 10
3
Calls
$26.6M
Puts
$8.4M
Top Buyers
| 1 | +$95.7M | |
| 2 | +$29.2M | |
| 3 | +$27.6M | |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
+$18M |
| 5 |
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Chicago,
Illinois
|
+$9.59M |
Top Sellers
| 1 | -$57.8M | |
| 2 | -$14.2M | |
| 3 | -$7.83M | |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$6.63M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$6.51M |